Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Clinical research

Candidate Ebola therapy fails to improve survival in clinical trial

Since the study was conducted on patients with advanced Ebola, the drug may be effective in those with less severe disease, researchers say.

Micrograph of ebola virus budding from cell

Source: National Institute of Allergy and Infectious Diseases (NIAID)

An experimental antiviral against Ebola virus (pictured) was tested as part of the RAPIDE clinical trial, but was quickly found not to be effective

The RAPIDE clinical trial was developed in 2014 to triage potential therapies for Ebola. It aimed to quickly eliminate therapies that are not effective using pre-specified futility boundaries that indicate when survival is no better than historic controls. 

In a phase II RAPIDE trial, researchers administered the candidate antiviral TKM-130803 daily for up to seven days to patients with confirmed Ebola in Sierra Leone. Two patients died within 48 hours. Of those who survived beyond two days, nine died and three survived. 

The trial was stopped after the enrolment of these 14 patients, when the futility boundary was met. 

Reporting in PLoS Medicine (online, 19 April 2016)[1], the researchers note that most patients in the study had advanced Ebola with high viral loads, and say the drug may still be effective in those with less severe disease.

Citation: The Pharmaceutical Journal DOI: 10.1211/CP.2016.20201081

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Micrograph of ebola virus budding from cell

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.